Noblis ESI Awarded Contract to Support Department of Defense Chemical and Biological Defense Initiatives


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Noblis ESI to provide support services for the Joint Enterprise-Research Development Acquisition Program

CHANTILLY, Va. (PRWEB) March 01, 2018

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Noblis, a leading provider of science, technology, and strategy services to the federal government, is pleased to announce that the company's wholly-owned subsidiary, Noblis ESI, has secured placement on the Joint Program Executive Office for Chemical and Biological Defense's Joint Enterprise-Research Development Acqusition Program. The $8 billion multi-award Indefinite Delivery/Indefinite Quantity (IDIQ) omnibus vehicle, competitively awarded, will support the JPEO-CBD mission to manage our nation's investments in chemical, biological, radiological, and nuclear (CBRN) defense equipment.

"Noblis ESI is proud to have the opportunity to expand our footprint in CBRN through this award, which further diversifies our unwavering support of the defense mission," said Vernon Ingram, President of Noblis ESI. "We look forward to delivering integrated capabilities, along with our team members, that will better enable the warfighter to remain secure and connected regardless of the operational environment"

With this award, Noblis will provide subject matter experts, capabilities, and contextual experience to support research, development, production, procurement, and fielding of Chemical, Biological, Radiological, and Nuclear (CBRN) defense systems, equipment, and materiel for the Department of Defense.

"The Noblis family of companies provides a wide spectrum of support to the chemical and biological defense mission- from medical countermeasures, to bioinformatics tools, to detection analysis," said Jordin Cohen, Noblis Vice President of Defense and Homeland Security. "Noblis has supported JPEO-CBD since 2009, and we look forward to continuing to ensure that our nation's warfighters remain capable and protected during all conditions."

###

About Noblis ESI
Noblis ESI is a wholly owned subsidiary of Noblis Inc., a nonprofit science, technology, and strategy organization. Noblis ESI specializes in providing the DoD and Intelligence Community with innovative engineering and technical solutions in C4ISR systems.

About Noblis
Noblis, Inc. is a nonprofit science, technology, and strategy organization that brings the best of scientific thought, management, and engineering expertise in an environment of independence and objectivity. We work with a wide range of government and industry clients in the areas of national security and intelligence, transportation and telecommunications, citizen services, environmental sustainability, and health. Together with our wholly owned subsidiaries, Noblis ESI and Noblis NSP, we tackle the nation's toughest problems and support our clients' most critical missions.

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/03/prweb15270262.htm


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.